Login / Signup

Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition.

Yannick WoutersM TheillaP SingerS TriblerP B JeppesenL PironiL Vinter-JensenH H RasmussenF RahmanG J A Wanten
Published in: Alimentary pharmacology & therapeutics (2018)
Clinicaltrials.gov, identifier: NCT01826526.
Keyphrases
  • clinical trial
  • end stage renal disease
  • ejection fraction
  • open label
  • newly diagnosed
  • healthcare
  • double blind
  • study protocol
  • patient reported outcomes